The Vaccines and Emerging Infections Subcommittees present a three-part webinar series to explore the evidence, development and implementation of vaccines for Bundibugyo ebolavirus disease.
The 38th study group was formed in the past week exploring the history, philosophy, and ethics of clinical microbiology and infectious diseases to provide perspective on current and future challenges.
